Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Times Interest Earned (2020 - 2025)

Barinthus Biotherapeutics (BRNS) has disclosed Times Interest Earned for 6 consecutive years, with -$1158.9 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned fell 110.04% year-over-year to -$1158.9, compared with a TTM value of -$1647.6 through Sep 2025, down 22.48%, and an annual FY2024 reading of -$1282.5, up 57.21% over the prior year.
  • Times Interest Earned was -$1158.9 for Q3 2025 at Barinthus Biotherapeutics, up from -$1943.7 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $8.84 in Q1 2022 and bottomed at -$2855.4 in Q4 2023.
  • Average Times Interest Earned over 5 years is -$1506.3, with a median of -$1554.2 recorded in 2024.
  • The sharpest move saw Times Interest Earned skyrocketed 76.02% in 2024, then crashed 110.04% in 2025.
  • Year by year, Times Interest Earned stood at -$926.0 in 2021, then soared by 100.95% to $8.84 in 2022, then crashed by 32409.13% to -$2855.4 in 2023, then skyrocketed by 31.74% to -$1949.2 in 2024, then skyrocketed by 40.54% to -$1158.9 in 2025.
  • Business Quant data shows Times Interest Earned for BRNS at -$1158.9 in Q3 2025, -$1943.7 in Q2 2025, and -$1584.6 in Q1 2025.